NCT05258110View on ClinicalTrials.gov

A Study in Healthy Men to Test Whether BI 425809 Influences the Amount of Midazolam in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 18, 2022

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Healthy
Interventions
DRUG

midazolam

midazolam

DRUG

BI 425809

BI 425809

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05258110 - A Study in Healthy Men to Test Whether BI 425809 Influences the Amount of Midazolam in the Blood | Biotech Hunter | Biotech Hunter